Skip to main content
logo
Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.240
+0.050 (1.57%)
Jul 3, 2025, 1:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Therapeutics
18.14M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-53.51%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
18.14M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-53.51%
Log In
Log In
Log In
Log In
Upgrade